Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Thrombocytopenia 14Leukemia, Myeloid, Acute 5Leukemia 3Jacobs syndrome 3Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Sarcoma 1Recurrence 1Purpura, Thrombocytopenic, Idiopathic 1Primary Myelofibrosis 1Pathologic Complete Response 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Chemotherapy-induced Thrombocytopenia 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1Anemia 1

Interventions

fludarabine phosphate 22Cyclophosphamide 20Busulfan 20Peripheral Blood Stem Cell Transplantation 16Cyclosporine 16Filgrastim 13Antilymphocyte Serum 13Mycophenolic Acid 11Melphalan 11Radiotherapy 10Methotrexate 10Cytarabine 10Methylprednisolone 9Cord Blood Stem Cell Transplantation 9Whole-Body Irradiation 8Tacrolimus 8Etoposide 8Granulocyte Colony-Stimulating Factor 5fludarabine 4Thiotepa 4Sirolimus 4Carboplatin 4Topotecan 3Leucovorin 3lintuzumab 2Vorinostat 2Tretinoin 2Therapeutics 2Immunoenzyme Techniques 2Idarubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Blast Crisis × eltrombopag × Classical hematology × Clear all
NCT01428635 2023-09-26

Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy

M.D. Anderson Cancer Center

Phase 2/3 Completed
21 enrolled 10 charts
Classical hematologyMyeloidOther hematologic neoplasm

Blast Crisis, Thrombocytopenia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡